Dog Demodectic Mange: Welfare Management of Immune-Related Parasites

Demodectic mange affects dogs with immune dysfunction and causes significant skin disease. Modern treatment has transformed welfare outcomes for affected dogs.

Key Facts

Demodex mites are normal skin inhabitants that proliferate when immune function is compromised
Generalized demodicosis causes widespread hair loss, skin thickening, and secondary infection
Juvenile onset often resolves with treatment while adult onset suggests underlying immune disease
Modern isoxazoline treatments including fluralaner and lotilaner are highly effective
Secondary bacterial pyoderma significantly worsens suffering and requires concurrent treatment

Welfare Considerations

Generalized demodectic mange causes significant suffering through widespread skin inflammation, hair loss, secondary bacterial infection causing pain and itching, and systemic illness from uncontrolled infection. The skin changes including thickening, odor, and crusting create severe welfare compromise. Before modern isoxazoline treatments, demodicosis was difficult to manage and some cases required prolonged, intensive treatment with older medications causing side effects. Current treatments are highly effective with minimal side effects, transforming the welfare outlook for affected dogs. Addressing underlying immune dysfunction or immunosuppressive disease concurrent with mite treatment is essential for preventing relapse.

What You Can Do

Seek veterinary diagnosis for any dog showing significant hair loss and skin thickening
Request skin scrapes to confirm the diagnosis of demodicosis
Follow the prescribed isoxazoline treatment course completely
Ensure concurrent treatment of secondary bacterial skin infections
Investigate underlying causes of immunosuppression in adult-onset cases
Schedule regular follow-up skin scrapes to confirm response to treatment